Historical review from 2026-11-21. Current price and availability are unconfirmed; check the original marketplace.
Hydrofy generates $232/mo revenue with exceptional 85% profit margins and trades at an attractive 2.06x annual profit multiple. However, the absolute revenue volume is minimal—$2.8K annualized—making this a very early-stage venture. Without visibility into user growth trajectory, churn, or customer acquisition channels, the deal presents meaningful execution risk despite favorable unit economics. This is a preliminary screen candidate rather than an established business.
The software itself—a mobile garden-planning app with pH/nutrient logging and AI-assisted diagnostics—is reproducible by a solo founder using modern AI coding tools, managed APIs (OpenAI for plant diagnosis logic), Firebase or Supabase for backend, and native iOS tooling or cross-platform frameworks like React Native. Build cost (AI subscriptions + hosting) would likely be $3.5K–$7.5K and achievable in 8–12 weeks. However, the acquisition verdict rests entirely on proven customer traction and durable acquisition channels. At $232/mo with no visible historical growth, churn data, or acquisition-channel proof, the business assets being purchased are minimal. The asking price ($4.9K) is attractive in isolation, but the near-zero recurring revenue base and lack of customer-retention visibility make BUILD the lower-risk choice unless the seller can demonstrate month-over-month growth, paying customer count in the double digits, and sub-10% monthly churn.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Hydrofy helps home hydroponic growers plan gardens, log pH and nutrient readings, track plants from seed to harvest, and spot problems with AI-assisted diagnosis on iPhone and iPad.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.